11/22/2011
Pharmalot.com
In a devastating blow to Novartis, a federal judge denied a bid to overturn a verdict in which a jury decided the drugmaker failed to a
|
9/23/2011
Originally posted at http://www.anewmerckreviewed.wordpress.com
Back in January 2011, immediately after the very-able Judge Keenan declined to
|
5/31/2011
By Derek Hawkins
Law360, New York (May 31, 2011) -- The U.S. Supreme Court refused Tuesday to take up Novartis Pharmaceuticals Corp.’s appeal of a
|
2/24/2011
Long-term use of oral bisphosphonates, such as Fosamax, Actonel and Reclast, increase the risk of rare, atypical thigh bone fractures, according to a
|
2/22/2011
ScienceDaily (Feb. 22, 2011) — Older women
who used bisphosphonates (medications that prevent loss of bone mass)
for five years or more were
|
2/22/2011
CNN.com
Osteoporosis, a condition where the bones become weak, affects 10 million people in the U.S. Two studies released Tuesday in the Journal of t
|
11/11/2010
By Ashby Jones - Wall Street Journal Blog Full Article Here: http://blogs.wsj.com/law/2010/11/11/jawbone-death-and-the-law-the-latest-fosam
|
11/10/2010
Safety Announcement[03-10-2010] Patients and healthcare professionals may have questions about oral bisphosphonate medications and atypical subtr
|
10/25/2010
Published By Jennifer P. Schneider, MD, PhD
Several recent medical articles have described multiple cases of unusual low-impact subtrochanteric stres
|
10/16/2010
By Gina KolataThe New York TimesPublished October 16, 2010
In the past month, the Food and Drug Administration has concluded that in some c
|
10/13/2010
By Duff Wilson via New York Times
Updated: The Food and Drug Administration issued a warning on Wednesday linking long-term use of pop
|
9/14/2010
By Ed Silverman Six months after the FDA determined there is no link between bisphosphonates and thigh-bone fractures, a task force says otherwis
|
9/14/2010
Published by The American Society For Bone and Mineral Research
Drugs
Commonly Prescribed for Osteoporosis Patients are Effective at Reducing
R
|
9/8/2010
Doctor leads effort to restrict the use of bone drug Fosamax.
Full Article Here: http://azstarnet.com/news/science/health-med-fit/article
|
6/25/2010
By Christie SmytheLaw360, New York (June 25, 2010) -- In the first-ever win on jawbone-death claims related to Merck & Co.’s osteoporosi
|
3/9/2010
By CHRISTINE ROMO and LARA SALAHI - GMA
Sandy Potter, 59 of Queens, New York, was jumping rope with neighborhood children when she felt her thigh bon
|
7/10/2009
Presently, we are conducting what is known as core discovery. The Judge in Newman, NJ has required that the parties select 12 cases from litigation. T
|
1/9/2009
By Jennifer Garvin
A new study in the January issue of The Journal of the American Dental Association suggests that the use of oral bisphosphonates c
|
10/26/2008
The Food and Drug Administration monitors the potential side effects of popular drugs in order to ensure public health and safety. Drugs such as Fosam
|
6/4/2008
Published by the Wall Street Journal
A study in the current issue of the Journal of Orthopedic Trauma links Merck’s osteoporosis drug Fosamax to a
|
11/1/2007
Published by Aetna InteliHealth
Two bone-building drugs may be linked to irregular heart rhythms. The drugs -- Reclast and Fosamax -- belong to the c
|
11/15/2006
From The American Dental Association - November 2006
In a retrospective study from the University of Southern California (USC), four percent of femal
|
6/7/2006
Published by Fosamax-information.com
What is alendronate or Fosamax®?Alendronate, or Fosamax® is a compound that can alter the cycle of bon
|
5/21/2006
Published by The Cancer Blog
Out of New Zealand comes reporting that four New Zealanders have suffered rotting jawbones after taking a bisphosphates
|
4/14/2006
Statement by Merck & Co.
Merck is committed to putting patients first and providing accurate information regarding the efficacy, safety and tole
|